| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $445.8M | +23.5% |
| Gross Profit | $298.1M | +29.8% |
| R&D Expense | $69.3M | +20.9% |
| SG&A Expense | $110.6M | +28.3% |
| Operating Income | $16.1M | +118.8% |
| Pre-tax Income | $25.7M | +133.6% |
| Income Tax | $1.6M | +172.7% |
| Net Income | $24.1M | +132.4% |
| EPS (Basic) | $0.32 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $239.1M | +10.5% |
| Accounts Receivable | $46.5M | +15.2% |
| Inventory | $21.8M | +34.9% |
| Current Assets | $372.3M | +30.3% |
| Total Assets | $1.30B | +16.6% |
| Current Liabilities | $78.6M | +28.4% |
| Total Liabilities | $124.1M | +75.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $75.1M | +69.8% |
| Capital Expenditures | $11.3M | +13.3% |
| Investing Cash Flow | -$56.3M | -472.4% |
| Financing Cash Flow | $4.9M | +72.9% |
| Free Cash Flow | $63.8M | +86.2% |
| +131.4% |
| EPS (Diluted) | $0.31 | +130.4% |
| Stockholders' Equity |
| $1.18B |
| +12.6% |